Berliner Boersenzeitung - Djibouti experiments with GM mosquito against malaria

EUR -
AED 4.130282
AFN 78.61198
ALL 98.040696
AMD 432.126763
ANG 2.012537
AOA 1031.188962
ARS 1280.259425
AUD 1.753726
AWG 2.026955
AZN 1.910634
BAM 1.954999
BBD 2.26949
BDT 136.783948
BGN 1.956244
BHD 0.423907
BIF 3344.707845
BMD 1.124524
BND 1.457116
BOB 7.766886
BRL 6.357834
BSD 1.123949
BTN 96.142457
BWP 15.168919
BYN 3.678293
BYR 22040.67404
BZD 2.257895
CAD 1.568436
CDF 3228.508563
CHF 0.936818
CLF 0.027486
CLP 1054.837633
CNY 8.107253
CNH 8.116748
COP 4689.265854
CRC 568.734067
CUC 1.124524
CUP 29.799891
CVE 110.219833
CZK 24.920558
DJF 200.158657
DKK 7.459418
DOP 66.176413
DZD 149.523439
EGP 56.069113
ERN 16.867863
ETB 152.551543
FJD 2.551152
FKP 0.842042
GBP 0.841684
GEL 3.081089
GGP 0.842042
GHS 13.712503
GIP 0.842042
GMD 81.532721
GNF 9736.010319
GTQ 8.628464
GYD 235.16618
HKD 8.800644
HNL 29.254012
HRK 7.533641
HTG 147.137556
HUF 402.647287
IDR 18468.622964
ILS 3.968508
IMP 0.842042
INR 96.212096
IQD 1472.475165
IRR 47356.519771
ISK 145.907295
JEP 0.842042
JMD 178.72676
JOD 0.797319
JPY 162.586001
KES 145.367168
KGS 98.339353
KHR 4499.376281
KMF 496.471912
KPW 1012.025329
KRW 1568.036965
KWD 0.34533
KYD 0.936625
KZT 575.449306
LAK 24308.254982
LBP 100709.226338
LKR 338.20141
LRD 224.808872
LSL 20.232209
LTL 3.320428
LVL 0.680214
LYD 6.161475
MAD 10.406536
MDL 19.55716
MGA 5072.966281
MKD 61.537144
MMK 2360.776946
MNT 4021.74616
MOP 9.061667
MRU 44.520756
MUR 51.694429
MVR 17.384961
MWK 1949.10528
MXN 21.671335
MYR 4.834301
MZN 71.855996
NAD 20.233288
NGN 1799.879366
NIO 41.364705
NOK 11.590803
NPR 153.826964
NZD 1.903566
OMR 0.432902
PAB 1.123949
PEN 4.148766
PGK 4.674085
PHP 62.692681
PKR 317.860645
PLN 4.247918
PYG 8977.321219
QAR 4.108316
RON 5.073968
RSD 117.185206
RUB 90.412119
RWF 1588.563156
SAR 4.217572
SBD 9.379014
SCR 15.979452
SDG 675.22808
SEK 10.880986
SGD 1.457136
SHP 0.883699
SLE 25.530054
SLL 23580.710152
SOS 642.342489
SRD 40.98722
STD 23275.380239
SVC 9.83497
SYP 14621.023431
SZL 20.226791
THB 37.159887
TJS 11.543885
TMT 3.941457
TND 3.373318
TOP 2.633754
TRY 43.686752
TTD 7.630432
TWD 33.941623
TZS 3030.59227
UAH 46.589208
UGX 4106.35379
USD 1.124524
UYU 47.090703
UZS 14452.077741
VES 105.937178
VND 29203.893103
VUV 136.526218
WST 3.036646
XAF 655.694137
XAG 0.03458
XAU 0.000347
XCD 3.039082
XDR 0.816922
XOF 655.688308
XPF 119.331742
YER 274.495339
ZAR 20.207593
ZMK 10122.068538
ZMW 30.468785
ZWL 362.096329
  • BCE

    0.3950

    21.965

    +1.8%

  • BCC

    -0.3400

    90.85

    -0.37%

  • RBGPF

    3.9600

    66.96

    +5.91%

  • CMSC

    -0.0020

    22.158

    -0.01%

  • RIO

    0.1600

    62.55

    +0.26%

  • JRI

    0.0600

    12.85

    +0.47%

  • BTI

    0.7300

    44.31

    +1.65%

  • NGG

    0.4300

    72.86

    +0.59%

  • VOD

    0.4550

    10.095

    +4.51%

  • CMSD

    -0.0285

    22.14

    -0.13%

  • RELX

    -0.1350

    54.895

    -0.25%

  • GSK

    0.3950

    38.355

    +1.03%

  • BP

    -0.1700

    29.23

    -0.58%

  • AZN

    0.5390

    70.229

    +0.77%

  • RYCEF

    0.0500

    10.96

    +0.46%

  • SCS

    -0.0200

    10.33

    -0.19%

Djibouti experiments with GM mosquito against malaria
Djibouti experiments with GM mosquito against malaria / Photo: Miguel SCHINCARIOL - AFP/File

Djibouti experiments with GM mosquito against malaria

Tens of thousands of genetically modified mosquitos are being released every week in Djibouti as the tiny Horn of Africa state experiments with a new weapon against an unprecedented malaria surge.

Text size:

East Africa faces a deadly new threat from the arrival of Anopheles stephensi, a mosquito native to Asia and the Middle East that thrives in urban areas and is immune to insecticides.

The World Health Organization (WHO) says the species is a key factor in an unprecedented spike in malaria cases in Djibouti and Ethiopia, and has been found in six other African countries so far.

In 2019, Abdoulilah Ahmed Abdi, health adviser to Djibouti's presidency, heard about a new invention being used primarily in Brazil against a dengue-carrying mosquito.

The so-called "Friendly" mosquito, created by British biotechnology firm Oxitec, is a genetically modified male that carries a protein ensuring its offspring will not survive.

Since only females bite, the idea is that GM males can be released in vast numbers without posing an additional risk to humans.

Djibouti launched the programme in May with the release of 40,000 GM mosquitos and on October 6, began weekly releases that will run for six months.

"We are trying to find with our partner Oxitec an innovative and sustainable solution that could have an impact on the whole region and the continent at large," said Abdi.

"We are very proud of it. It's an initiative for all Africa," he added.

Abdi said results were expected by mid-2025 and that Djibouti was also building a factory to produce the mosquito for shipment across Africa.

- Hopes and challenges -

Oxitec has released well over one billion GM mosquitos in Brazil and Florida in the United States, where it targets the dengue-carrying Aedes aegypti.

Its studies indicate it can reduce wild populations by 90 percent or more.

"There's nothing better at finding the biting disease-transmitting female mosquito than a male mosquito," Neil Morrison, Oxitec's chief strategy officer, told AFP.

He emphasised the Djibouti programme was still at a pilot stage.

"Early next year, we'll start to figure out how many mosquitoes we'll need to release to deliver suppression," he said.

GM mosquitos are controversial with some environmentalists.

A 2019 report led by GeneWatch UK said Oxitec's technology risked altering the evolution of mosquitos and the way diseases spread, in potentially dangerous ways.

It questioned Oxitec's claims of efficacy, saying it could inadvertently release many females alongside its sterile males, or simply push wild mosquitos into neighbouring areas.

Oxitec insists its GM mosquito is "completely harmless and non-toxic" and regulators cleared it for deployment in the US in 2022.

But if GM mosquitos must be continuously released to be effective, there is the question of cost -- a key factor in Africa, which accounts for around 95 percent of the 600,000 malaria deaths each year.

Oxitec refused tell AFP how much its mosquitos cost to governments and private buyers.

Outside experts are taking a wait-and-see approach.

"We are very supportive of innovation," said Dorothy Achu, WHO's head of tropical and vector-borne diseases in Africa.

She said WHO was working on a regulatory framework to measure the impact of GM methods.

"Initial results are very promising but we need things that are sustainable over time and we need impact on wide areas," said Achu.

(B.Hartmann--BBZ)